Related Experiment Video
Updated: Aug 6, 2026
09:53
An In Vitro Model for Studying Cellular Transformation by Kaposi Sarcoma Herpesvirus
Published on: August 25, 2017
Signal transduction targets in Kaposi's sarcoma
Ryan Sullivan1, Bruce J Dezube, Henry B Koon
1Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA.
Current Opinion in Oncology
|August 9, 2006
Summary
AIDS-related Kaposi
Area of Science:
- Oncology
- Virology
- Immunology
Background:
- AIDS-related Kaposi's sarcoma (KS) arises from co-infection with HIV and Kaposi's sarcoma herpesvirus/human herpesvirus-8 (KSHV/HHV-8).
- KSHV/HHV-8 infection triggers an angiogenic-inflammatory state crucial for KS pathogenesis.
- Understanding KSHV/HHV-8 signaling pathways is key to KS pathogenesis.
Purpose of the Study:
- To review recent discoveries in KSHV/HHV-8 infection and signal transduction.
- To elucidate the pathogenesis of Kaposi's sarcoma.
- To identify potential therapeutic targets for KS.
Main Methods:
- Review of recent scientific literature on KSHV/HHV-8 and KS.
- Analysis of KSHV/HHV-8 specific and cellular signaling pathways involved in KS.
- Examination of findings from recent clinical trials of targeted KS therapies.
Main Results:
- KS is driven by KSHV/HHV-8 specific pathways (e.g., viral G protein-coupled receptor, viral IL-6).
- KSHV/HHV-8 hijacks cellular growth/angiogenic pathways (e.g., VEGF, IGF, PDGF).
- KSHV/HHV-8 signaling pathways represent promising therapeutic targets.
Conclusions:
- Recent advances significantly enhance the understanding of KS pathogenesis.
- Targeted therapies based on KSHV/HHV-8 pathways are emerging.
- These findings signal a paradigm shift in managing AIDS-related KS.
More Related Videos
Related Concept Videos
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
01:22Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...